Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
PLoS One ; 19(3): e0300774, 2024.
Article in English | MEDLINE | ID: mdl-38536789

ABSTRACT

INTRODUCTION: The global and Albanian populations of elderly people are steadily increasing. It is estimated that the number of elderly adults requiring care in Albania will rise from 90.9 thousand to 130.4 thousand by 2030. Despite the envisaged increase in the number and life expectancy of the elderly population in Albania, which will result in an increased demand for nursing care, little is known about the difficulties and challenges that nurses face while providing care for elderly Albanian individuals. AIM: To explore the difficulties and challenges nurses experience while caring for elderly people in Albanian eldercare institutions. METHODS: The study employed a qualitative design using purposive sampling of 20 nurses in 8 eldercare institutions who participated in face-to-face semi-structured interviews. The audio-recorded interviews were transcribed and subsequently subjected to analysis using Graneheim and Lundman's qualitative conventional content analysis. Data analysis was supported by the qualitative data analysis software MAXQDA 2020. The reporting of this study followed the consolidated criteria for reporting qualitative research (COREQ) checklist. RESULTS: Five key categories emerged from data analysis: (1) professional difficulties, (2) educational difficulties, (3) relationship challenges, (4) increased mental stress, and (5) participation in advocacy. This study showed that nursing staff experienced many barriers, challenges, and unmet needs when implementing care for elderly people in long-term care facilities. CONCLUSION: The findings indicate that nurses working in eldercare institutions faced significant challenges in caring for elderly people. Nurses need more legal, financial, educational, and emotional support. The study indicates that more organizational and national support is necessary for nursing staff to care for elderly people in eldercare Albanian institutions properly. Eldercare institution leaders need to recognize the importance of their role in overcoming the barriers and providing adequate support for their staff in caring for elderly people.


Subject(s)
Life Expectancy , Nursing Staff , Adult , Humans , Aged , Albania , Qualitative Research , Health Facilities
2.
Sci Rep ; 11(1): 14373, 2021 Jul 13.
Article in English | MEDLINE | ID: mdl-34257347

ABSTRACT

The electronic ground state of iron-based materials is unusually sensitive to electronic correlations. Among others, its delicate balance is profoundly affected by the insertion of magnetic impurities in the FeAs layers. Here, we address the effects of Fe-to-Mn substitution in the non-superconducting Sm-1111 pnictide parent compound via a comparative study of SmFe[Formula: see text]Mn[Formula: see text]AsO samples with [Formula: see text] 0.05 and 0.10. Magnetization, Hall effect, and muon-spin spectroscopy data provide a coherent picture, indicating a weakening of the commensurate Fe spin-density-wave (SDW) order, as shown by the lowering of the SDW transition temperature [Formula: see text] with increasing Mn content, and the unexpected appearance of another magnetic order, occurring at [Formula: see text] and 20 K for [Formula: see text] and 0.10, respectively. We attribute the new magnetic transition at [Formula: see text], occurring well inside the SDW phase, to a reorganization of the Fermi surface due to Fe-to-Mn substitutions. These give rise to enhanced magnetic fluctuations along the incommensurate wavevector [Formula: see text], further increased by the RKKY interactions among Mn impurities.

3.
Comput Biol Med ; 103: 269-276, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30408656

ABSTRACT

BACKGROUND: Muscles of individuals with Cerebral Palsy (CP) undergo structural changes over their lifespan including an increase in muscle stiffness, decreased strength and coordination. Being able to identify these changes non-invasively would be beneficial to improve understanding of CP and assess therapy effectiveness over time. This study aims to adapt an existing EMG-driven Hill-type muscle model for neuromuscular characterisation during isometric contractions of the elbow joint. METHODS: Participants with (n = 2) and without CP (n = 8) performed isometric force ramps with contraction levels ranging between 15 and 70% of their maximum torque. During these contractions, high-density EMG data were collected from the M. Biceps and Triceps brachii with 64 electrodes on each muscle. The EMG-driven Hill-type muscle model was used to predict torques around the elbow joint, and muscle characterisation was performed by applying a genetic algorithm that tuned individuals' parameters to reduce the RMS error between observed and predicted torque data. RESULTS: Observed torques could be predicted accurately with an overall mean error of 1.24Nm ± 0.53Nm when modelling individual force ramps. The first four parameters of the model could be identified relatively reliably across different experimental protocols with a full-scale variation of below 20%. CONCLUSION: An HD-EMG muscle modelling approach to evaluating neuromuscular properties in participants with and without CP has been presented. This pilot study confirms the feasibility of the experimental protocol and demonstrates some parameters can be identified robustly using the isometric contraction force ramps.


Subject(s)
Cerebral Palsy/physiopathology , Isometric Contraction/physiology , Models, Biological , Muscle, Skeletal/physiopathology , Adult , Algorithms , Elbow Joint/physiopathology , Electromyography , Female , Humans , Male , Muscle Strength Dynamometer , Signal Processing, Computer-Assisted , Young Adult
4.
Eur J Clin Microbiol Infect Dis ; 36(11): 2179-2186, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28695355

ABSTRACT

To provide optimal cut-off values of anti-Middle East respiratory syndrome coronavirus (MERS-CoV) serologic tests, we evaluated performance of ELISA IgG, ELISA IgA, IFA IgM, and IFA IgG using 138 serum samples of 49 MERS-CoV-infected patients and 219 serum samples of 219 rRT-PCR-negative MERS-CoV-exposed healthcare personnel and patients. The performance analysis was conducted for two different purposes: (1) prediction of neutralization activity in MERS-CoV-infected patients, and (2) epidemiologic surveillance of MERS-CoV infections among MERS-CoV-exposed individuals. To evaluate performance according to serum collection time, we used 'days post onset of illness (dpoi)' and 'days post exposure (dpex)' assessing neutralization activity and infection diagnosis, respectively. Performance of serologic tests improved with delayed sampling time, being maximized after a seroconversion period. In predicting neutralization activity, ELISA IgG tests showed optimal performance using sera collected after 21 dpoi at cut-off values of OD ratio 0.4 (sensitivity 100% and specificity 100%), and ELISA IgA showed optimal performance using sera collected after 14 dpoi at cut-off value of OD ratio 0.2 (sensitivity 85.2% and specificity 100%). In diagnosis of MERS-CoV infection, ELISA IgG exhibited optimal performance using sera collected after 28 dpex, at a cut-off value of OD ratio 0.2 (sensitivity 97.3% and specificity 92.9%). These new breakpoints are markedly lower than previously suggested values (ELISA IgG OD ratio 1.1, sensitivity 34.8% and specificity 100% in the present data set), and the performance data help serologic tests to be practically used in the field of MERS management.


Subject(s)
Antibodies, Viral/blood , Coronavirus Infections/diagnosis , Enzyme-Linked Immunosorbent Assay/methods , Middle East Respiratory Syndrome Coronavirus/immunology , Serologic Tests/methods , Coronavirus Infections/blood , Coronavirus Infections/immunology , Coronavirus Infections/virology , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Sensitivity and Specificity
5.
Immunol Lett ; 160(2): 145-50, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24472604

ABSTRACT

The monoclonal antibody SM201 specifically recognizes the human inhibitory FcγRIIB without showing cross-reactivity to the related but activating FcγRIIA. The epitope recognized by SM201 is located outside the IgG-binding site of FcγRIIB. As a result, the antibody does not interfere with hIgG binding to the receptor. It was therefore hypothesized that SM201 may amplify the inhibitory signaling of FcγRIIB after coligation of B cell receptor (BCR) and FcγRIIB by immune complexes (ICs). Mechanistic and functional studies were conducted in established B cell lines as well as in primary B cells from healthy donors to substantiate the anticipated working principle. Using an experimental setup mimicking IC binding, we were able to demonstrate that SM201 enhances the extent of ITIM phosphorylation of FcγRIIB. The antibody works synergistically with ICs and the mode of action is strictly dependent on their presence. Additionally, SM201 did not induce apoptosis, cellular depletion or NK cell activation, which indicates an advantageous safety profile. This establishes an innovative approach for the treatment of antibody-mediated autoimmune diseases.


Subject(s)
Antibodies, Monoclonal/immunology , B-Lymphocytes/drug effects , Receptors, IgG/immunology , Recombinant Fusion Proteins/immunology , Animals , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/pharmacology , Antibody Affinity , Antibody Specificity , Antigen-Antibody Complex/genetics , Antigen-Antibody Complex/immunology , Antigen-Antibody Complex/pharmacology , B-Lymphocytes/cytology , B-Lymphocytes/immunology , CHO Cells , Cell Line, Tumor , Cricetulus , Gene Expression Regulation , Humans , Hybridomas/chemistry , Hybridomas/immunology , Immunoglobulin G/genetics , Immunoglobulin G/immunology , Ligands , Primary Cell Culture , Protein Binding , Rats , Receptors, Antigen, B-Cell/agonists , Receptors, Antigen, B-Cell/genetics , Receptors, Antigen, B-Cell/immunology , Receptors, IgG/antagonists & inhibitors , Receptors, IgG/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/pharmacology , Signal Transduction
6.
Infection ; 42(1): 203-6, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23900771

ABSTRACT

We report a case of a 45-year-old patient who developed severe acute respiratory distress syndrome accompanied by renal failure. An infection with a novel human coronavirus was confirmed and found to be the reason for rapidly progressive respiratory failure of our patient.


Subject(s)
Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Coronavirus/classification , Coronavirus/isolation & purification , Respiratory Insufficiency/diagnosis , Respiratory Insufficiency/etiology , Coronavirus Infections/parasitology , Humans , Lung/diagnostic imaging , Lung/pathology , Male , Middle Aged , Radiography, Thoracic , Respiratory Insufficiency/virology , Tomography, X-Ray Computed
7.
Euro Surveill ; 18(50): 20662, 2013 Dec 12.
Article in English | MEDLINE | ID: mdl-24342516

ABSTRACT

Between June and September 2013, sera from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected in Jordan, where the first human Middle-East respiratory syndrome (MERS) cluster appeared in 2012. All sera were tested for MERS-coronavirus (MERS-CoV) specific antibodies by protein microarray with confirmation by virus neutralisation. Neutralising antibodies were found in all camel sera while sera from goats and cattle tested negative. Although six sheep sera reacted with MERS-CoV antigen, neutralising antibodies were not detected.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Camelus/blood , Coronavirus/immunology , Animals , Cattle , Coronavirus/isolation & purification , Coronavirus Infections/blood , Female , Goats/blood , Humans , Jordan , Livestock , Microarray Analysis , Middle East , Neutralization Tests , Real-Time Polymerase Chain Reaction , Respiratory Tract Infections/etiology , Sheep/blood , Syndrome
8.
Euro Surveill ; 18(14): 20441, 2013 Apr 04.
Article in English | MEDLINE | ID: mdl-23594517

ABSTRACT

We present a serological assay for the specific detection of IgM and IgG antibodies against the emerging human coronavirus hCoV-EMC and the SARS-CoV based on protein microarray technology. The assay uses the S1 receptor-binding subunit of the spike protein of hCoV-EMC and SARS-CoV as antigens. The assay has been validated extensively using putative cross-reacting sera of patient cohorts exposed to the four common hCoVs and sera from convalescent patients infected with hCoV-EMC or SARS-CoV.


Subject(s)
Coronavirus/genetics , Protein Array Analysis , Coronavirus/classification , Coronavirus/isolation & purification , Coronavirus Infections/blood , Coronavirus Infections/parasitology , Female , Humans , Male , Sequence Homology, Amino Acid
9.
Euro Surveill ; 18(8)2013 Feb 21.
Article in English | MEDLINE | ID: mdl-23449231

ABSTRACT

On 24 October 2012, a patient with acute respiratory distress syndrome of unknown origin and symptom onset on 5 October was transferred from Qatar to a specialist lung clinic in Germany. Late diagnosis on 20 November of an infection with the novel Coronavirus (NCoV) resulted in potential exposure of a considerable number of healthcare workers. Using a questionnaire we asked 123 identified contacts (120 hospital and three out-of-hospital contacts) about exposure to the patient. Eighty-five contacts provided blood for a serological test using a two-stage approach with an initial immunofluorescence assay as screening test, followed by recombinant immunofluorescence assays and a NCoV-specific serum neutralisation test. Of 123 identified contacts nine had performed aerosol-generating procedures within the third or fourth week of illness, using personal protective equipment rarely or never, and two of these developed acute respiratory illness. Serology was negative for all nine. Further 76 hospital contacts also tested negative, including two sera initially reactive in the screening test. The contact investigation ruled out transmission to contacts after illness day 20. Our two-stage approach for serological testing may be used as a template for similar situations.


Subject(s)
Contact Tracing , Coronavirus Infections/diagnosis , Coronavirus/isolation & purification , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Respiratory Distress Syndrome/etiology , Coronavirus/genetics , Coronavirus/immunology , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Delayed Diagnosis , Disease Notification , Female , Fluorescent Antibody Technique, Indirect , Germany , Health Personnel/statistics & numerical data , Humans , Infectious Disease Transmission, Patient-to-Professional/statistics & numerical data , Male , Middle Aged , Neutralization Tests , Occupational Exposure , Qatar , Real-Time Polymerase Chain Reaction , Respiratory Distress Syndrome/epidemiology , Retrospective Studies , Risk Assessment , Risk Factors , Surveys and Questionnaires , Travel , Treatment Outcome
10.
Euro Surveill ; 17(49)2012 Dec 06.
Article in English | MEDLINE | ID: mdl-23231891

ABSTRACT

We present a rigorously validated and highly sensitive confirmatory real-time RT-PCR assay (1A assay) that can be used in combination with the previously reported upE assay. Two additional RT-PCR assays for sequencing are described, targeting the RdRp gene (RdRpSeq assay) and N gene (NSeq assay), where an insertion/deletion polymorphism might exist among different hCoV-EMC strains. Finally, a simplified and biologically safe protocol for detection of antibody response by immunofluorescence microscopy was developed using convalescent patient serum.


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction/methods , Coronavirus/classification , Coronavirus/genetics , Coronavirus Infections/virology , Fluorescent Antibody Technique , Germany , Humans , Laboratories/standards , Polymorphism, Restriction Fragment Length , RNA, Viral/blood , RNA, Viral/genetics , Sensitivity and Specificity , Sequence Analysis, DNA , Virology/methods
11.
Euro Surveill ; 17(39)2012 Sep 27.
Article in English | MEDLINE | ID: mdl-23041020

ABSTRACT

We present two real-time reverse-transcription polymerase chain reaction assays for a novel human coronavirus (CoV), targeting regions upstream of the E gene (upE) or within open reading frame (ORF)1b, respectively. Sensitivity for upE is 3.4 copies per reaction (95% confidence interval (CI): 2.5­6.9 copies) or 291 copies/mL of sample. No cross-reactivity was observed with coronaviruses OC43, NL63, 229E, SARS-CoV, nor with 92 clinical specimens containing common human respiratory viruses. We recommend using upE for screening and ORF1b for confirmation.


Subject(s)
Coronavirus Infections/virology , Real-Time Polymerase Chain Reaction/methods , Severe acute respiratory syndrome-related coronavirus/genetics , Severe acute respiratory syndrome-related coronavirus/isolation & purification , Coronavirus 229E, Human/genetics , Coronavirus 229E, Human/isolation & purification , Coronavirus Infections/diagnosis , Coronavirus Infections/genetics , Coronavirus NL63, Human/genetics , Coronavirus NL63, Human/isolation & purification , Coronavirus OC43, Human/genetics , Coronavirus OC43, Human/isolation & purification , Humans , Open Reading Frames , Saudi Arabia , Sensitivity and Specificity , Travel , Viral Envelope Proteins , Viroporin Proteins
12.
Praxis (Bern 1994) ; 101(2): 107-14, 2012 Jan 18.
Article in German | MEDLINE | ID: mdl-22252592

ABSTRACT

Only a standartized, systematic approach allows a complete review of a chest x-ray and the collection of all relevant informations. In detail, alterations of the following structures should be sought: soft tissue, bones, pleura, mediastinum, lung, heart, pulmonary circulation and hili. Technical factors and the position of the patient should also be considered.


Subject(s)
Education, Medical, Continuing , Radiography, Thoracic/methods , Thoracic Diseases/diagnostic imaging , Humans , Sensitivity and Specificity
13.
Clin Radiol ; 64(7): 682-9, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19520212

ABSTRACT

AIM: To assess whether a simple. diameter-based formula applicable to cross-sectional images can be used to calculate the total liver volume. MATERIALS AND METHODS: On 119 cross-sectional examinations (62 computed tomography and 57 magnetic resonance imaging) a simple, formula-based method to approximate the liver volume was evaluated. The total liver volume was approximated measuring the largest craniocaudal (cc), ventrodorsal (vd), and coronal (cor) diameters by two readers and implementing the equation: Vol(estimated)=cc x vd x cor x 0.31. Inter-rater reliability, agreement, and correlation between liver volume calculation and virtual liver volumetry were analysed. RESULTS: No significant disagreement between the two readers was found. The formula correlated significantly with the volumetric data (r>0.85, p<0.0001). In 81% of cases the error of the approximated volume was <10% and in 92% of cases <15% compared to the volumetric data. CONCLUSION: Total liver volume can be accurately estimated on cross-sectional images using a simple, diameter-based equation.


Subject(s)
Anthropometry/methods , Liver/anatomy & histology , Adult , Aged , Algorithms , Female , Humans , Image Processing, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Liver/diagnostic imaging , Magnetic Resonance Imaging/methods , Male , Middle Aged , Organ Size , Tomography, X-Ray Computed/methods , Young Adult
14.
Endocr Relat Cancer ; 15(1): 277-88, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18310294

ABSTRACT

Although several tumour types express both AT1 and AT2 angiotensin II receptors, and angiotensin II stimulates cell proliferation, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are not effective anti-cancer agents. Development of a biologically active monoclonal antibody (6313/G2) against the AT1 receptor prompted the testing of a recombinant short-chain variable fragment form (R6313/G2) against breast cancer cells in vitro and in vivo. Cell lines MCF-7, MDA-MB-231 and T47D all expressed both receptor subtypes. In vitro, R6313/G2 suppressed cell proliferation in the presence of 100 nM angiotensin II, with IC50s of 30 nM, 153 nM and 2.8 microM for the three cell types respectively; in contrast, the AT1 receptor blocker losartan was effective only in T47D cells, at 25 microM. Studies on MCF-7 and T47D cells showed R6313/G2 also opposed the angiotensin II-induced inhibition of caspase-3/7 activity. In vivo, hollow fibres containing the cell lines were implanted in nu/nu balb-c mice at two sites, s.c. and i.p. Treatments of R6313/G2 at 2.5 nmol/kg and 25 nmol/kg twice per day for 7 days dose dependently reduced cell numbers for all three cell lines, but here MCF-7 cells responded most sensitively and MDA-MB-231 cells least. Although T47D cells were refractory at the s.c. site, growth was inhibited at the i.p. location, and otherwise results were similar at the two sites. In xenografts, MCF-7 cell tumours were dose dependently reduced by R6313/G2, and 13 and 27 nmol/kg R6313/G2 twice/day gave means of 74 and 76% tumour regression after 7 days. The data suggest that the anti-cancer action of R6313/G2 is considerably more effective than AT1 antagonists.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Breast Neoplasms/immunology , Breast Neoplasms/therapy , Receptor, Angiotensin, Type 1/immunology , Receptor, Angiotensin, Type 2/immunology , Recombinant Proteins/therapeutic use , Angiotensin II/pharmacology , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Angiotensin II Type 2 Receptor Blockers , Animals , Apoptosis , Blood Pressure Determination , Blotting, Western , Breast Neoplasms/metabolism , Caspases/metabolism , Cell Survival , Female , Humans , Immunoglobulin Fragments/genetics , Immunoglobulin Fragments/immunology , Losartan/therapeutic use , Mice , Mice, Inbred BALB C , Peptide Fragments/immunology , Peptide Fragments/metabolism , Rats , Rats, Wistar , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 2/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Tumor Cells, Cultured , Vasoconstrictor Agents/pharmacology , Xenograft Model Antitumor Assays
15.
Ultrasound Obstet Gynecol ; 30(1): 11-8, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17559183

ABSTRACT

OBJECTIVES: To study the outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency thickness (NT), with respect to fetal loss, structural defects and genetic syndromes with developmental delay, and to provide information that would be helpful for parental counseling on the residual risk of adverse outcome when ultrasound findings are normal. METHODS: We reviewed the outcome of all pregnancies presenting at the Academic Medical Centre in Amsterdam with increased NT between January 1994 and March 2005. Fetal karyotyping and two-step ultrasound investigation at 13-18 and 20-24 weeks' gestation were offered in all cases. Particular attention was paid to the relationship between normal karyotype, ultrasound findings at the 20-24-week scan and subsequent pregnancy outcome. An adverse outcome was defined as miscarriage, intrauterine death, termination of pregnancy at parental request or the finding of one or more structural defects or genetic disorders. RESULTS: A total of 675 fetuses with increased NT, known karyotype and known pregnancy outcome was analyzed. A chromosomal anomaly was detected in 224 (33%) fetuses. In 451 (67%) fetuses, the karyotype was normal. The overall incidence of an adverse pregnancy outcome in this group was 19% and, when analyzed according to the initial degree of increase in NT, the likelihood of an adverse outcome increased with increasing NT, ranging from 8% to 80%. 425 fetuses underwent a detailed second-trimester ultrasound scan. Anomalies were detected, at the time of ultrasound or after birth, in 54 (13%) of these fetuses (17 isolated cardiac defects, 14 other structural defects and 23 genetic disorders). An adverse pregnancy outcome was recorded in 4% of cases in which there were normal findings at the 20-week scan. Seven of these cases were classified as 'potentially amenable' to ultrasound detection. With exclusion of these cases, the chance of a healthy baby, if the 20-week scan was completely normal, was 98%. Genetic syndromes with dysmorphic features and neurodevelopmental delay occurred in seven (1.6%) of the fetuses with normal karyotype. In three of these pregnancies, non-specific suspicious ultrasound findings (nuchal edema, mild pyelectasis, pericardial effusion) were observed at the mid-trimester scan and in two others, subtle cardiac defects were detected after delivery. In the remaining two cases (0.5%) the mid-trimester scan was completely normal and no structural defects were observed after delivery. CONCLUSION: After exclusion of chromosomal anomalies, one out of five fetuses with increased NT has an adverse pregnancy outcome. The chance of an uneventful pregnancy outcome depends on the initial degree of increase in NT. However, if the detailed ultrasound examination at around 20 weeks is normal, a favorable outcome can be expected with confidence, irrespective of initially increased NT.


Subject(s)
Chromosome Aberrations/embryology , Chromosome Disorders/diagnostic imaging , Fetal Diseases/diagnostic imaging , Neck/diagnostic imaging , Nuchal Translucency Measurement/methods , Parents/psychology , Chromosome Disorders/diagnosis , Diagnosis, Differential , Female , Fetal Diseases/diagnosis , Humans , Pregnancy , Pregnancy Outcome , Pregnancy, High-Risk/psychology , Prognosis , Risk Factors , Sensitivity and Specificity
16.
Prenat Diagn ; 27(2): 164-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17238215

ABSTRACT

OBJECTIVE: To assess the performance of nuchal translucency (NT) measurement in the first trimester of pregnancy as a marker for congenital heart defects (CHD) in the fetus in a low-risk obstetric population. METHODS: Nuchal translucency screening was offered over a 3-year period to consecutive pregnant women without known a priori risk factors and attending midwife practices in three different areas in the Netherlands. In chromosomally normal fetuses and infants from the study population the NT measurements were matched with CHD detected either prenatally or postnatally. RESULTS: NT screening was offered to 6132 women with an uptake of 83%. A total of 4876 NT measurements was performed. Pregnancy outcome data were available in 4181 cases (86%). Defects of the heart and great arteries (CHD) were diagnosed in 24 cases (prevalence 5.8/1000). Thirteen of these were classified as major (prevalence 3.1/1000). Two major CHD occurred in fetuses showing an increased NT at the first-trimester scan. The sensitivity of NT measurement > 95th and > 99th percentile for all CHD and for major CHD, was 8% and 15%, respectively. The positive likelihood ratios of NT > 95(th) and > 99th percentile for major CHD were 6, 5 and 33, respectively. CONCLUSION: In pregnancies without known risk factors also, an increased NT is associated with major cardiac defects in the fetus and therefore represents an indication for specialized fetal echocardiography. However, this association is too weak to envisage a role for NT measurement as single screening strategy for the prenatal detection of cardiac defects.


Subject(s)
Fetal Diseases/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Neck/diagnostic imaging , Nuchal Translucency Measurement , Adult , Confidence Intervals , Epidemiologic Methods , Female , Fetal Diseases/epidemiology , Heart Defects, Congenital/epidemiology , Humans , Mass Screening/methods , Mass Screening/statistics & numerical data , Neck/embryology , Netherlands/epidemiology , Nuchal Translucency Measurement/statistics & numerical data , Pregnancy , Pregnancy Outcome , Prevalence , Risk Factors , Sensitivity and Specificity , Ultrasonography, Prenatal
17.
JBR-BTR ; 90(6): 467-74, 2007.
Article in English | MEDLINE | ID: mdl-18376758

ABSTRACT

Since its introduction in the late 70's 3D imaging has assumed growing importance for the visualization of abdominal pathologies. Main clinical applications include the preoperative planning for resection of liver, pancreas and kidney tumors, living-donor liver and renal transplantation, and tumor radiofrequency ablation of liver and kidney. The advantages of 3D imaging are the exact visualization of vessels in areas with complex and variable vascular anatomy, demonstration of possible resection margins, and predicting operative risks, especially when dealing with complex or minimal invasive surgery. 3D imaging is an important visual aid for the surgeon in order to facilitate crucial decisions and to lower the operative risk. In future, 3D planning and simulation of operations will be become standard procedures. Therefore an efficient use of 3D imaging is not possible without a close collaboration between radiologist and surgeons.


Subject(s)
Imaging, Three-Dimensional , Radiography, Abdominal/methods , Algorithms , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Patient Care Planning , Tomography, X-Ray Computed
19.
Ultrasound Obstet Gynecol ; 27(4): 357-61, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16565991

ABSTRACT

OBJECTIVES: To compare levels of anxiety and depression during pregnancy and puerperium between women who are offered nuchal translucency (NT) screening routinely and those who are not, and to compare levels between women accepting and those declining screening. METHODS: In 12 midwife practices in three different health districts an experimental NT screening program was offered to pregnant women between 1 June 1999 and 1 January 2001. As part of this implementation study, questionnaires including the Hospital Anxiety and Depression Scale (HADS) were completed: after the patient was informed but before screening (T1), at 20 weeks of gestation (T2), and 6 weeks after delivery (T3). A control group of women receiving routine prenatal care (i.e. no screening offered) also completed the HADS questionnaire at 12 and 20 weeks and after delivery. RESULTS: Five hundred and twenty-seven questionnaires were analyzed. There was a screening uptake of 87% in the intervention group (i.e. those offered screening). Women in this group differed significantly in the percentage of previous miscarriages and religious background compared with the control group. We adjusted for these differences in the analysis. There were no significant differences in HADS scores between the intervention and the control groups at T1, suggesting that women receiving information on screening were not more anxious compared with women who were not informed. Women who were offered screening (acceptors as well as decliners) had significantly lower HADS levels at 20 weeks and after delivery. There were no demographic differences between women accepting and those declining screening. CONCLUSION: Informing women and offering them NT screening for Down syndrome does not increase anxiety or depression levels in pregnancy. In fact, women undergoing or declining screening seem less anxious compared with those who are not offered screening. It is possible that informing women and offering them the chance to decide autonomously whether to participate in screening reduces anxiety levels.


Subject(s)
Anxiety/etiology , Depression/etiology , Down Syndrome/diagnostic imaging , Nuchal Translucency Measurement/psychology , Pregnancy/psychology , Adult , Case-Control Studies , Female , Humans , Infant, Newborn , Netherlands , Patient Compliance , Patient Education as Topic , Patient Selection , Postpartum Period/psychology , Psychiatric Status Rating Scales , Statistics, Nonparametric
20.
Arch Virol ; 150(5): 1023-31, 2005 May.
Article in English | MEDLINE | ID: mdl-15645376

ABSTRACT

In order to define and characterize target cells of SARS-coronavirus (SARS-CoV) we studied the susceptibility of 23 different permanent and primary eukaryotic cell lines to SARS-coronavirus. Beneath Vero E6 cells SARS- Coronavirus infection could also be demonstrated in two pig cell lines (POEK, PS) and one human cell line (Huh-7) using the indirect immunofluorescence assay and a newly established quantitative real-time PCR. In all susceptible cell lines mRNA of the Angiotensin-converting enzyme 2 (ACE2), the functional receptor for SARS-CoV infection, could be detected by RT-PCR. Our results show that there is a correlation between the abundance of ACE2 mRNA and SARS-CoV susceptibility.


Subject(s)
Eukaryotic Cells/virology , Severe acute respiratory syndrome-related coronavirus/pathogenicity , Angiotensin-Converting Enzyme 2 , Animals , Carboxypeptidases/genetics , Carboxypeptidases/metabolism , Cats , Cell Line , Chlorocebus aethiops , Humans , Mice , Peptidyl-Dipeptidase A , Receptors, Virus/genetics , Receptors, Virus/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Severe acute respiratory syndrome-related coronavirus/genetics , Severe acute respiratory syndrome-related coronavirus/physiology , Swine , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...